|
Market Cap (4-Jul) $171,348,752 (477th) |
Close (30-Jun) $0.99 |
Volume (30-Jun) 1,077,429 |
Shortsold (19-Jun) 1,473,254 (0.38%) (338th) |
|
52w High $0.66 |
52w Low $0.165 |
P/E - |
EPS -0.05 |
PAR released this announcement to the ASX on 12 January 2021, 17:33. The announcement is not marked as price sensitive, and is 16 page(s) in length and 14.31MB in size.
You can view all announcements from PAR and see how they appear on a price chart on the announcements page.
At the date of this announcement, PAR was 4.341% short sold according to ASIC data. It was ranked the 35th most shorted stock on the ASX. It remains ranked 338th as of the latest reported data (19 June 2025).
| Other Recent Announcements from PAR | |
|---|---|
| Notification of cessation of securities - PAR | 29 June 2023, 16:43 |
| Primary and Secondary endpoints met in MPS I Trial | 6 June 2023, 12:28 |
| iPPS shows 3-year equivalent durability in OA Canine Study | 1 June 2023, 8:21 |
| 39th Annual JP Morgan Healthcare Conference Presentation | 12 January 2021, 17:33 |
| Paradigm to present at the J.P. Morgan Healthcare Conference | 6 January 2021, 8:23 |
| R&D Investor Presentation | 21 December 2020, 9:17 |
| PARADIGM RECEIVES POSTIVE FEEDBACK FROM FDA TYPE C MEETING | 18 December 2020, 8:40 |
You must be logged in to post a reply.
Paradigm Biopharmaceuticals 